Influence of Hypoxia on Electroretingraphy (ERG) Measurements

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by University Hospital Tuebingen.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01246024
First received: November 22, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
  Purpose

To investigate the influence of induced hypoxia on the ERG.


Condition Intervention
ERG Under Hypoxia
Device: ERG

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Further study details as provided by University Hospital Tuebingen:

Primary Outcome Measures:
  • Electroretingraphy Measurements [ Time Frame: 01.02.2011-01.06.2011 ] [ Designated as safety issue: No ]

Estimated Enrollment: 30
Study Start Date: February 2011
Estimated Study Completion Date: April 2013
Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Hypoxia Device: ERG
scotopic and photopic ERG

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy subjects

Exclusion Criteria:

  • under 18 and over 80 years, respiratory diseases, cataracta and corneal hazes, myopia more than 6 dpt, hyperopia more than 3 dpt, allergy for any topical anesthetics in ophthalmology, photic epilepsy, asthma bronchiale.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01246024

Contacts
Contact: Florian Gekeler, Prof. Dr. med. +4970712987461 fgekeler@googlemail.com

Locations
Germany
Centre for Ophthalmology Not yet recruiting
Tübingen, Germany, D-72076
Contact: Andreas Schatz    +70712987461    schatzweb@gmail.com   
Sponsors and Collaborators
University Hospital Tuebingen
  More Information

No publications provided

Responsible Party: Prof. Dr. med. Florian Gekeler, Centre for Ophthalmology
ClinicalTrials.gov Identifier: NCT01246024     History of Changes
Other Study ID Numbers: THS0001
Study First Received: November 22, 2010
Last Updated: November 22, 2010
Health Authority: Germany: Ethics Commission

Additional relevant MeSH terms:
Anoxia
Signs and Symptoms, Respiratory
Signs and Symptoms

ClinicalTrials.gov processed this record on July 23, 2014